Cargando…

Contrast nephropathy: Risk factors and the role of beta blockers

Detalles Bibliográficos
Autor principal:	Bowden, Rodney G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2015
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337061/ https://www.ncbi.nlm.nih.gov/pubmed/25880176 http://dx.doi.org/10.5152/akd.2015.14769

Ejemplares similares

A clinical study about contrast nephropathy: Risk factors and the role of beta blockers
por: Akgüllü, Çağdaş, et al.
Publicado: (2015)

Beta-blockers in refractory hypoxemia on venovenous extracorporeal membrane oxygenation: a double-edged sword
por: Staudacher, Dawid L., et al.
Publicado: (2023)

β-blockers in hemodialysis: simple questions, complicated answers
por: Hundemer, Gregory L, et al.
Publicado: (2020)

How to Boost Efficacy of a Sodium Channel Blocker: The Devil Is in the Details
por: Nowak, Madison B., et al.
Publicado: (2019)

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

Beta-blocker therapy in pediatric heart failure: 50 years lost to improve pharmacotherapy of a deadly disease
por: Buchhorn, Reiner
Publicado: (2021)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Clinical Impact of Beta-blockers in the Revascularization Era
por: Kang, Soo-Jin
Publicado: (2020)

Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
por: Carriazo, Sol, et al.
Publicado: (2020)

Solving the riddle of Aguascalientes nephropathy: nephron number, environmental toxins and family clustering
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Beta-Blockers: A Tale of Triumphs, Trials, and Tribulations
por: Singh, Jagjit
Publicado: (2020)

Late contrast enhancement by CMR: more than scar?
por: van der Wall, Ernst E., et al.
Publicado: (2008)

Low-dose CT angiography: sufficient contrast for vessel imaging?
por: van der Wall, E. E., et al.
Publicado: (2009)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism
por: Kereliuk, Stephanie M., et al.
Publicado: (2023)

Meta-analysis of effect of renin–angiotensin–aldosterone system blockers on contrast-induced nephropathy
por: Wang, Weidong, et al.
Publicado: (2020)

Beta-blocker therapy in refractory ascites: A steady march towards the truth
por: Bartell, Nicholas, et al.
Publicado: (2022)

Tyrosine kinase inhibitor-induced hypertension—marker of anti-tumour treatment efficacy or cardiovascular risk factor?
por: Ptinopoulou, Anastasia G., et al.
Publicado: (2020)

Risk factors for inguinal lymph node metastasis in patients with penile cancer
por: Koifman, Leandro
Publicado: (2022)

Interferon beta-1b for COVID-19
por: Shalhoub, Sarah
Publicado: (2020)

HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
por: Curtiss, Frederic R.
Publicado: (2008)

Chronic limb threatening disease, diabetic nephropathy and diabetic retinopathy in patients with type 1 diabetes
por: Jonas, Jost B.
Publicado: (2023)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Why consider contrast-enhanced ultrasound (ce-US) in children?: Editorial comment on: M.M. Woźniak, A. Pawelec, A.P. Wieczorek, M.M. Zajączkowska, H. Borzęcka and P. Nachulewicz 2D/3D/4D contrast-enhanced voiding urosnography in the diagnosis and monitoring of treatment of vesicoureteral reflux in children – can it replace voiding cystourethrography?
por: Riccabona, Michael
Publicado: (2014)

Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction
por: Hale, Taben M., et al.
Publicado: (2019)

Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefined
por: Fishbane, Steven, et al.
Publicado: (2023)

Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression
por: Calvani, Maura, et al.
Publicado: (2020)

Does preoperative beta-blocker offer myocardial protection during coronary artery bypass grafting?
por: Rocha, Bruno da Costa
Publicado: (2013)

ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker
por: Lainscak, Mitja, et al.
Publicado: (2016)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

The Role of Macrophages in Nonischemic Heart Failure
por: Chen, Bijun, et al.
Publicado: (2018)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Anti-Black racism in academia and what you can do about it
por: Bowden, Audrey K., et al.
Publicado: (2021)

Intensity of hydration changes the role of renin–angiotensin–aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease
por: Guo, Xiao-sheng, et al.
Publicado: (2017)

Editorial Comment: Diabetes Is a Risk Factor for Inflatable Penile Prosthesis Infection: Analysis of a Large Statewide Database
por: Lokeshwar, Soum D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mb2t8tgid9mldok4l9k2sdjoe